158 related articles for article (PubMed ID: 10084724)
1. Neuropsychological development in children with Hurler syndrome following hematopoietic stem cell transplantation.
Peters C; Shapiro EG; Krivit W
Pediatr Transplant; 1998 Nov; 2(4):250-3. PubMed ID: 10084724
[No Abstract] [Full Text] [Related]
2. Outcome in six children with mucopolysaccharidosis type IH, Hurler syndrome, after haematopoietic stem cell transplantation (HSCT).
Malm G; Gustafsson B; Berglund G; Lindström M; Naess K; Borgström B; von Döbeln U; Ringdén O
Acta Paediatr; 2008 Aug; 97(8):1108-12. PubMed ID: 18452566
[TBL] [Abstract][Full Text] [Related]
3. Mixed donor chimerism and low level iduronidase expression may be adequate for neurodevelopmental protection in Hurler Syndrome.
Conway J; Dyack S; Crooks BN; Fernandez CV
J Pediatr; 2005 Jul; 147(1):106-8. PubMed ID: 16027706
[TBL] [Abstract][Full Text] [Related]
4. Gross motor development of children with hurler syndrome after umbilical cord blood transplantation.
Dusing SC; Thorpe DE; Poe MD; Rosenberg AE; Mercer VS; Escolar ML
Phys Ther; 2007 Nov; 87(11):1433-40. PubMed ID: 17785373
[TBL] [Abstract][Full Text] [Related]
5. Oral busulfan pharmacokinetics and engraftment in children with Hurler syndrome and other inherited metabolic storage diseases undergoing hematopoietic cell transplantation.
Jacobson P; Park JJ; DeFor TE; Thrall M; Abel S; Krivit W; Peters C
Bone Marrow Transplant; 2001 Apr; 27(8):855-61. PubMed ID: 11477444
[TBL] [Abstract][Full Text] [Related]
6. Analysis of factors affecting development of carpal tunnel syndrome in patients with Hurler syndrome after hematopoietic cell transplantation.
Khanna G; Van Heest AE; Agel J; Bjoraker K; Grewal S; Abel S; Krivit W; Peters C; Orchard PJ
Bone Marrow Transplant; 2007 Mar; 39(6):331-4. PubMed ID: 17277793
[TBL] [Abstract][Full Text] [Related]
7. Transplantation of allogeneic CD34-selected stem cells after fludarabine-based conditioning regimen for children with mucopolysaccharidosis 1H (M. Hurler).
Grigull L; Beilken A; Schrappe M; Das A; Luecke T; Sander A; Stanulla M; Rehe K; Sauer M; Schmid H; Welte K; Lukacs Z; Gal A; Sykora KW
Bone Marrow Transplant; 2005 Feb; 35(3):265-9. PubMed ID: 15580280
[TBL] [Abstract][Full Text] [Related]
8. Developmental outcome in five children with Hurler syndrome after stem cell transplantation: a pilot study.
Lücke T; Das AM; Hartmann H; Sykora KW; Donnerstag F; Schmid-Ott G; Grigull L
Dev Med Child Neurol; 2007 Sep; 49(9):693-6. PubMed ID: 17718826
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH).
Koç ON; Day J; Nieder M; Gerson SL; Lazarus HM; Krivit W
Bone Marrow Transplant; 2002 Aug; 30(4):215-22. PubMed ID: 12203137
[TBL] [Abstract][Full Text] [Related]
10. Developmental outcomes in children with Hurler syndrome after stem cell transplantation.
Dusing SC
Dev Med Child Neurol; 2007 Sep; 49(9):646. PubMed ID: 17718818
[No Abstract] [Full Text] [Related]
11. The clinical outcome of Hurler syndrome after stem cell transplantation.
Aldenhoven M; Boelens JJ; de Koning TJ
Biol Blood Marrow Transplant; 2008 May; 14(5):485-98. PubMed ID: 18410891
[TBL] [Abstract][Full Text] [Related]
12. Combination of enzyme replacement and hematopoietic stem cell transplantation as therapy for Hurler syndrome.
Tolar J; Grewal SS; Bjoraker KJ; Whitley CB; Shapiro EG; Charnas L; Orchard PJ
Bone Marrow Transplant; 2008 Mar; 41(6):531-5. PubMed ID: 18037941
[TBL] [Abstract][Full Text] [Related]
13. Temporal and spatial gait characteristics of children with Hurler syndrome after umbilical cord blood transplantation.
Dusing SC; Thorpe DE; Mercer VS; Rosenberg AE; Poe MD; Escolar ML
Phys Ther; 2007 Aug; 87(8):978-85. PubMed ID: 17553918
[TBL] [Abstract][Full Text] [Related]
14. Combined enzyme replacement and haematopoietic stem cell transplantation in Hurler syndrome.
Bijarnia S; Shaw P; Vimpani A; Smith R; Pacey V; O'Grady H; Christodoulou J; Sillence D
J Paediatr Child Health; 2009; 45(7-8):469-72. PubMed ID: 19712183
[TBL] [Abstract][Full Text] [Related]
15. Outcome of second hematopoietic cell transplantation in Hurler syndrome.
Grewal SS; Krivit W; Defor TE; Shapiro EG; Orchard PJ; Abel SL; Lockman LA; Ziegler RS; Dusenbery KE; Peters C
Bone Marrow Transplant; 2002 Mar; 29(6):491-6. PubMed ID: 11960268
[TBL] [Abstract][Full Text] [Related]
16. Incidence and prevalence of mucopolysaccharidosis type 1 in the Irish republic.
Murphy AM; Lambert D; Treacy EP; O'Meara A; Lynch SA
Arch Dis Child; 2009 Jan; 94(1):52-4. PubMed ID: 18463126
[TBL] [Abstract][Full Text] [Related]
17. Outcome of 27 patients with Hurler's syndrome transplanted from either related or unrelated haematopoietic stem cell sources.
Souillet G; Guffon N; Maire I; Pujol M; Taylor P; Sevin F; Bleyzac N; Mulier C; Durin A; Kebaili K; Galambrun C; Bertrand Y; Froissart R; Dorche C; Gebuhrer L; Garin C; Berard J; Guibaud P
Bone Marrow Transplant; 2003 Jun; 31(12):1105-17. PubMed ID: 12796790
[TBL] [Abstract][Full Text] [Related]
18. Musculoskeletal manifestations in mucopolysaccharidosis type I (Hurler syndrome) following hematopoietic stem cell transplantation.
Schmidt M; Breyer S; Löbel U; Yarar S; Stücker R; Ullrich K; Müller I; Muschol N
Orphanet J Rare Dis; 2016 Jul; 11(1):93. PubMed ID: 27392569
[TBL] [Abstract][Full Text] [Related]
19. [Allogeneic hematopoietic stem cell transplantation for the treatment of mucopolysaccharidosis type 1: a case report].
Ou RM; Wang L; Zheng LL; Yao MD; Jiang WT; Zhou CH
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun; 8(3):181-3. PubMed ID: 16787585
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic bone marrow stem cell transplantation following CD34+ immunomagnetic enrichment in patients with inherited metabolic storage diseases.
Gaipa G; Dassi M; Perseghin P; Venturi N; Corti P; Bonanomi S; Balduzzi A; Longoni D; Uderzo C; Biondi A; Masera G; Parini R; Bertagnolio B; Uziel G; Peters C; Rovelli A
Bone Marrow Transplant; 2003 May; 31(10):857-60. PubMed ID: 12748661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
